Early research (Phase 1)Study completedNCT01625936What this trial is testingCRLX101 Plus Bevacizumab in Advanced RCCWho this might be right forRenal Cell Carcinoma Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Study completedNCT00203892What this trial is testingStudy of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma University of Chicago 23
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Testing effectiveness (Phase 2)Study completedNCT01369420What this trial is testingNanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Angiodynamics, Inc. 10
Large-scale testing (Phase 3)Study completedNCT03013010What this trial is testingPREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyWho this might be right forStomach NeoplasmGastroEsophageal CancerAdenocarcinoma+2 more Shanghai Cancer Hospital, China 204
Testing effectiveness (Phase 2)Study completedNCT00719550What this trial is testingAMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction CancerWho this might be right forEsophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer Amgen 130
Testing effectiveness (Phase 2)Ended earlyNCT00085410What this trial is testingBortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderWho this might be right forAdenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Looking for participantsNCT05813015What this trial is testingStudy of Comparing of With and Without Sequential Therapy of S-1Who this might be right forLocally Advanced Gastric AdenocarcinomaChemotherapy Effect Zhejiang University 70
Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT05440708What this trial is testingTTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Tvardi Therapeutics, Incorporated 193
Not applicableNo Longer AvailableNCT04087876What this trial is testingExpanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic AlterationsWho this might be right forIntrahepatic Cholangiocarcinoma Basilea Pharmaceutica
Testing effectiveness (Phase 2)Study completedNCT05299476What this trial is testingCAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEAWho this might be right forAdvanced Gastroesophageal AdenocarcinomaFirst-line TherapyPDL1 CPS < 5 Chinese PLA General Hospital 32
Large-scale testing (Phase 3)Looking for participantsNCT06346197What this trial is testingCombination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasWho this might be right forGastric CancerMSI-HMetastatic Cancer+1 more Centre Leon Berard 132
Large-scale testing (Phase 3)UnknownNCT01523015What this trial is testingEfficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal Junction Medical University of Lublin 100
Early research (Phase 1)UnknownNCT05396326What this trial is testingA Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerWho this might be right forGastric Cancer Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289What this trial is testingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more Rahul Aggarwal 83
Testing effectiveness (Phase 2)UnknownNCT01237665What this trial is testingIXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal CancerWho this might be right forRectal Cancer Ottawa Hospital Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00551421What this trial is testingPertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT02387216What this trial is testingMM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLCWho this might be right forNon-Small Cell Lung CancerNSCLCAdenocarcinoma+1 more Elevation Oncology 153
Testing effectiveness (Phase 2)Study completedNCT01588704What this trial is testingNeoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung AdenocarcinomaWho this might be right forLung Cancer Si-Yu Wang 42